REbif FLEXible Dosing in Early Multiple Sclerosis (MS) (Q65385451)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | REbif FLEXible Dosing in Early Multiple Sclerosis (MS) |
clinical trial |
Statements
REFLEX (English)
0 references
A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial of Rebif New Formulation (44 Microgram [Mcg] Three Times Weekly [Tiw] and 44 Mcg Once Weekly [ow]) in Subjects at High Risk of Converting to Multiple Sclerosis (REFLEX) (English)
0 references
November 2006
0 references
August 2010
0 references
517
0 references
18 year
0 references
50 year
0 references